RCS - Dr. Martens PLC - Appointment of Market General Managers

Dr MartensAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260408:nRSH5187Za&default-theme=true

RNS Number : 5187Z  Dr. Martens PLC  08 April 2026

 

DR. MARTENS MOVES TO MARKET GENERAL MANAGER STRUCTURE AND CREATES EXECUTIVE
TEAM TO ACCELERATE STRATEGIC DELIVERY

 

8 April 2026: Dr. Martens today announces the appointment of General Managers
(GM) for all major markets, as part of the approach to simplify the operating
model in line with the new consumer-first strategy.

In order to embed and deliver the new strategy, we have made several
organisational changes, moving to a market level structure to be closer to the
consumer, combined with strengthening Global Brand, Technology and Support
functions.

We are pleased to announce Nick Duff as UK GM, Nathalie Schneider as France
GM, Kristin Staeren as DACH GM and Giorgio Trevisan as Italy GM. All four are
internal promotions and their talent and experience will be instrumental to
growing consumers in their markets.

We also recently welcomed Yoichi Oikawa as our new Japan GM. Yoichi has
extensive experience in consumer engagement, multi-channel and building teams
across Japan and APAC, most notably for Champion and Adidas. The USA market
continues to be directly run by Paul Zadoff, President of Americas.

These six markets are each significant for our business, accounting for over
80% of global revenues, and the new market structure will ensure each market
is run by a dedicated leader and team.

Dr. Martens is also simplifying the leadership structure, with a newly created
Executive Team ("ET"), led by CEO Ije Nwokorie. This Executive Team will set
business direction and will be comprised of:

 * Ije Nwokorie: CEO

 * Giles Wilson: CFO, with Technology and Strategy both now reporting into Giles

 * Carla Murphy: Chief Brand Officer, including Product, Marketing, Customer
Experience and Sustainability

 * Anna Duffiet: Chief Operating Officer (interim)

 * Mike Stopforth: Chief Commercial Officer, with the Market GMs reporting into
this newly created global role, together with Growth and Partner markets

 * Paul Zadoff: President of Americas

 * Bridget Jolliffe: Chief People Officer

 * Katherine Bellau: Chief Legal Officer and Company Secretary

 

Ije Nwokorie, CEO of Dr. Martens, said: "Over the past year we have
reorganised our business and ways of working so that we are truly
consumer-first, as opposed to channel-led. I am excited to work alongside our
leadership team, combining experienced Dr. Martens leaders and world-class
talent from some of the most desired global brands. They will each play a
significant role in helping us to deliver against our strategy and scale the
business in the years ahead."

 

Ends

 

 

Investors and
analysts:

Bethany Barnes, Director of Investor Relations & Corporate Communications

bethany.barnes@drmartens.com (mailto:bethany.barnes@drmartens.com)

+44782187465

 

Press enquiries:

Rob Greening / Ludo Baynham-Herd

drmartens@client.sodali.com (mailto:drmartens@client.sodali.com)

+44 207 250 1446

 

Notes to editors

About Dr. Martens

 

Dr. Martens is an iconic British footwear brand founded in Northamptonshire,
England. Its first silhouette, the 1460 boot - named after the date it was
produced - rolled off the production line on 1st April 1960. Originally chosen
by workers for their air-cushioned comfort and durability, "Docs" or "DM's"
were later adopted by musicians and subcultural pioneers who took them from
the street to the global stage.

Over six decades later, Dr. Martens operates in more than 60 countries and
employs around 3,700 people. The company continues to honour the brand's
heritage through its 'Made in England' footwear, manufactured at its original
Northamptonshire factory, while meeting global demand from multiple
high-quality production sites across Asia. All our products are made with an
unwavering commitment to craft, combined with innovative techniques.

A brand built to put a bounce in the step of those who stand out from the
crowd, Dr. Martens is available through Direct-to-Consumer (Retail and
Ecommerce) and Wholesale channels. The brand's collections range from its
Original silhouettes - The Icons such as the 1460 boot, 1461 shoe, 2976
Chelsea boot, and Adrian loafer - to modern franchises like the Zebzag, Buzz,
and Lowell. The lineup also includes an extensive range of sandals, a
dedicated Kids collection, and a curated selection of bags, small leather
goods, and accessories.

Every Dr. Martens collection reflects craftsmanship, heritage, timeless style,
comfort, and versatility. Having transcended generations, the brand stays as
relevant today as it was at its inception. Its signature yellow welt
stitching, grooved sole edges, and scripted "With Bouncing Soles" heel loops
remain iconic symbols recognised around the world.

Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock
Exchange and is a constituent of the FTSE 250 index.

For more information, visit www.drmartens.com or www.drmartensplc.com

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASSSFIWEMSELL



            Copyright 2019 Regulatory News Service, all rights reserved